Molecular targeted vaccine - International Cancer Laboratory
Alternative Names: HER2 vaccine therapy -International Cancer Laboratory; Molecular Targeted Vaccine Therapy -International Cancer LaboratoryLatest Information Update: 10 May 2022
At a glance
- Originator International Cancer Laboratory
- Class Antineoplastics; Cancer vaccines
- Mechanism of Action ERBB 2 receptor modulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Solid tumours
Most Recent Events
- 06 May 2022 Clinical trials in Solid tumours in Japan (Parenteral) (UMIN000047665)